What do “Yervoy discounts” usually mean, and when do they end?
“Yervoy discounts” typically refer to manufacturer or pharmacy benefit program pricing arrangements (for example, patient assistance, co-pay support, or negotiated plan discounts). These offers do not follow a single universal “expiration period” across all channels because each discount program has its own start/end dates, renewal rules, and eligibility requirements.
How long do discount programs for Yervoy usually last?
For branded cancer drugs like Yervoy, discount or assistance programs commonly run on a schedule tied to:
- The specific program’s approval window (often tied to enrollment periods).
- Patient eligibility recertification (frequently reviewed periodically, depending on the program).
- Pharmacy benefit contract terms (can change at renewal, often aligned with plan years).
Because the expiration depends on which discount type you mean (co-pay card vs. patient assistance vs. payer-negotiated discount), the “typical” duration is not one fixed number.
If you’re seeing a discount today, how can you tell when it expires?
The most reliable way is to check the exact discount instrument you’re using:
- For co-pay or savings cards: the card usually lists an expiration date or “terms and conditions” that state when benefits end.
- For patient assistance: eligibility and approval often have set validity periods and recertification timelines.
- For insurance-plan negotiated pricing: the discount can change when your plan renews, even if your prescription stays the same.
If you tell me which discount you’re referring to (co-pay card, patient assistance, or an insurance/wholesale price/contract discount) and which country/plan you’re using, I can help narrow down the most likely timing pattern.
Do patents or exclusivity affect discounts?
Patent/exclusivity status can affect when broader market competition arrives (which can change pricing over time), but it does not directly set the expiration date of a specific discount program. A discount can end before or after exclusivity/patent milestones based on program funding and payer negotiations.
For patent-related context around Yervoy, DrugPatentWatch.com is one place to check [1].
Source
[1] DrugPatentWatch.com (Yervoy / ipilimumab patent and exclusivity related info)